The efficacy of first-line antiretroviral therapy (ART) continues to improve, according to an analysis of outcomes in 78,000 people in 181 studies, published in AIDS by Professor Andrew Carr of St Vincent's Hospital in Sydney and colleagues.
Currently, there is a Standard Treatment Guideline and Essential Medicines List (STG/EML) available for use by health workers at public health care settings in Eswatini; which was published in 2012. Considering the numerous changes in policies, guidelines, and new scientific evidence that informs clinical practice, there is a compelling need to revise and update this guideline so that it remains relevant to the users. It’s widely believed that the current STG has not been used extensively due to a number of factors. TSP/SC-PASS has obtained approval from the Principal Secretary, MOH, Eswatini to support the review, update of the treatment guideline and hereby wishes to engage the services of competent consultant(s) to undertake some aspects of this project as specified below.
In recent years, an overwhelming body of clinical evidence has firmly established the HIV Undetectable = Untransmittable (U=U) concept as scientifically sound, say officials from the National Institutes of Health.
In 2016, the Prevention Access Campaign, a health equity initiative with the goal of ending the HIV/AIDS pandemic as well as HIV-related stigma, launched the Undetectable = Untransmittable (U = U) initiative. U = U signifies that individuals with HIV who receive antiretroviral therapy (ART) and h
The South African Health Review 2018 is now available. This year’s edition focuses on human resources for health - particularly innovative and practical solutions for ensuring adequate human resources in preparation for National Health Insurance (NHI) - and emphasises the need for sustainable progress in staffing the health sector if we are to achieve universal health coverage. Download the Review in its entirety or by individual chapter from the Health Systems Trust’s website.
In most developing economies particularly in Africa, more people are likely to die of HIV/AIDS and malaria compared to other diseases. HIV/AIDS tends to be superimposed on the long standing malaria burden particularly in sub-Saharan Africa. The detection and understanding of spatial overlaps in disease occurrence is important for integrated and targeted disease control. Integrated disease control can enhance efficiency and cost-effectiveness through the development of drugs targeting multiple infections in the same geographic space.